Myelo Therapeutics secures Series B funding - MarketLine Financial Deals

Myelo Therapeutics secures Series B funding

Myelo Therapeutics secures Series B funding - MarketLine Financial Deals
Myelo Therapeutics secures Series B funding
Published Jan 08, 2016
2 pages — Published Jan 08, 2016
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Myelo Therapeutics GmbH, a Germany-based pharmaceutical company, has secured Series B round of funding.

  
Source:
Document ID
MA163770_160112
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Myelo Therapeutics secures Series B funding" Jan 08, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Myelo-Therapeutics-secures-Series-B-funding-2052-117194>
  
APA:
MarketLine Financial Deals. (2016). Myelo Therapeutics secures Series B funding Jan 08, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Myelo-Therapeutics-secures-Series-B-funding-2052-117194>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.